β-Blocker Use and Cardiovascular Outcomes in Hemodialysis: A Systematic Review
Author:
Publisher
Elsevier BV
Subject
Nephrology,Internal Medicine
Reference21 articles.
1. Beta blockade after myocardial infarction: systematic review and meta regression analysis;Freemantle;BMJ,1999
2. Beta-blockade in chronic dialysis patients;Furgeson;Semin Dial,2008
3. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial;Agarwal;Nephrol Dial Transplant,2014
4. Inc. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients;Am J Kidney Dis,2005
5. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare part D;Frankenfield;Am J Kidney Dis,2012
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path;Reviews in Cardiovascular Medicine;2024-06-25
2. Point-of-Care Clinical Trials in Nephrology;Journal of the American Society of Nephrology;2024-02-29
3. Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease;The American Journal of Medicine;2023-12
4. Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis;Biomedicines;2023-10-19
5. Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients;International Journal of Nephrology and Renovascular Disease;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3